Search all trials

Find therapies in clinical trials near you – page 36

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Multiple sclerosis

Not recruiting

Registered drugNo placebo

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo

France

Participants:18–64 years
Substances:Ocrelizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

InvestigationalNo placebo

Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Sunvozertinib

Contact Research Centre

Myocarditis

Not recruiting

InvestigationalNo placebo

Study on the Effect of Cannabidiol (CardiolRx) on Heart Recovery in Patients with Acute Myocarditis

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cannabidiol

Contact Research Centre

Ovarian epithelial cancer

Not recruiting

Registered drugNo placebo

Study on Niraparib's Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Niraparib Tosilate Monohydrate

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Glycogen storage disease type II

Not recruiting

InvestigationalNo placebo

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cipaglucosidase Alfa

Contact Research Centre

Pituitary-dependent Cushing's syndrome

Not recruiting

InvestigationalNo placebo

Study of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ag13909

Contact Research Centre

Breast cancer+1

Not recruiting

Registered drugNo placebo

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Glioma

Not recruiting

Investigational

Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

Investigational

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Vorasidenib

Contact Research Centre

Glioblastoma

Not recruiting

InvestigationalNo placebo

Study of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Pegargiminase

Contact Research Centre

Dementia Alzheimer's type+1

Not recruiting

InvestigationalNo placebo

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Lecanemab

Contact Research Centre

Atrial fibrillation+2

Not recruiting

Registered drug

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Apixaban

Contact Research Centre

Find therapies in clinical trials near you – page 36

472 trials match your criteria

Multiple sclerosis

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Non-small cell lung cancer

Study on the Safety and Effectiveness of Sunvozertinib for Patients with Advanced Non-Small Cell Lung Cancer with EGFR or HER2 Mutations

Myocarditis

Study on the Effect of Cannabidiol (CardiolRx) on Heart Recovery in Patients with Acute Myocarditis

Ovarian epithelial cancer

Study on Niraparib's Effects and Safety in Patients with High-Grade Serous Ovarian Cancer

Non-small cell lung cancer

Study Comparing Adagrasib and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Glycogen storage disease type II

Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

Pituitary-dependent Cushing's syndrome

Study of Lu AG13909 in Adults with Cushing's Disease to Evaluate Safety and Effectiveness

Breast cancer+1

Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

Glioma

Study of Vorasidenib for Patients with Residual or Recurrent Grade 2 Glioma with IDH1 or IDH2 Mutation

Glioblastoma

Study of Troriluzole and ADI-PEG-20 for Patients with Newly Diagnosed and Recurrent Glioblastoma

Dementia Alzheimer's type+1

Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months

Atrial fibrillation+2

Study on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.